https://rss.com/podcasts/oncology-s-green-light AI-Powered Insights into the Latest FDA Approvals for Everyday Oncology Clinicians

]]> RSS.com 2026.401.141116 Fri, 17 Apr 2026 14:09:27 GMT en d75205f7-dbd0-5c1f-b50e-797921a15cf5 https://media.rss.com/oncology-s-green-light/20250415_050421_4d93d0b0615825fe50aefcbb6ccc50f2.png https://rss.com/podcasts/oncology-s-green-light yes OncologyResearch 2025 OncologyResearch OncologyResearch false episodic podcast Explore the latest breakthroughs in treating MSI-H/dMMR metastatic colorectal cancer with immune therapies! This episode dives into the exciting world of immune checkpoint inhibitors (ICIs) like nivolumab (Opdivo) and ipilimumab (Yervoy), highlighting their significant clinical benefits for this specific patient population. Learn about the molecular characteristics of MSI-H/dMMR CRC that make it uniquely sensitive to immunotherapy. Our AI hosts will cover pivotal clinical trials, including CheckMate 8HW, which demonstrated the improved progression-free survival with the combination of nivolumab and ipilimumab compared to nivolumab alone. Discover how immunotherapy is becoming a new standard of care for MSI-H/dMMR metastatic CRC.

]]> https://rss.com/podcasts/oncology-s-green-light/1988468 3e4a0b5b-3a0e-466b-bd91-635f6df80a9b 1082 full 1 1 10 10 false Tue, 15 Apr 2025 18:01:16 GMT